Biomedical subjects
Publications and source records attributed to G Pi.
Pyomyositis is most commonly caused by Staphylococcus aureus. A 25-month-old child developed infection of the biceps brachialis muscle caused by Streptococcus pneumoniae. The child had no underlying immune or anatomic defect.
OBJECTIVE: To study the therapeutic effect of Chinese medicinal herbs on HIV patients. METHODS: We adopted the combined Chinese medicinal herbs for treatment, its chief component is to enhance human immunity and the complementary part is suited for lightening the clinical synptoms. The clinical aspects, the CD4, CD8 lymphocyte numbers and the plasma viral load of the patients were compared before and after the treatment. RESULTS: Of 28 patients exemined, they all had different degrees of body weight increasing, averagely increased 5.4 kg after treatment. 7 cases having a long-time fever, 4 cases of diarrhea, 2 cases of large scale skin ulcer and 1 case of skin rash all had their synptoms disappeared ofter one month treatment. 10 cases, who had lymph nodes enlargement, after treated five months with Chinese medicinal herbs, 3 of them the swelling lymph nodes disappeared, 7 of them the lymph nodes diminished or decreased in number. CD4 lymphocytes increased in 42.9% and 50.0% patients and viral load decreased in 71.4% and 80.0% patients after two months and five months treatment with Chinese medicinal herbs respectively. Taking clinical symptoms and laboratory indexs into consideration, the total effective rate of Chinese medicinal herbs reached 94.0%. CONCLUSION: The Chinese medicinal herbs can obviously improve the clinical symptoms, increase CD4 lymphocytes and decrease serum viral load of the HIV patients, thus provides evidence that the Chinese medicinal herbs can be used for control of HIV infection and treatment of AIDS patients.
OBJECTIVE: To establish the monoclonal antibodies of HIV and HCV for developing serological diagnostic method. METHODS: The antigens of HIV gp41 and HCV NS3 expressed from bacteria were mixed to immunize BALB/c mice. The hybridoma cell lines were obtained by fusing SP2/0 myeloma cells with spleen cells from immunized mice. RESULTS: Four hybridoma cell lines secreting specific antibodies against gp41 of HIV and six hybridoma cell lines secreting antibodies to NS3 of HCV were obtained. ELISA sandwich method for detection of viral antigens with McAbs was developed. CONCLUSION: A quick and convenient method for obtaining McAbs was developed using mixture of different antigens for immunizition of mice. The monoclonal antibodies had high senusitivity and were stably secreted by hybridoma cell lines. This technique is worthy to be popularized.
An enzyme-linked immunosorbent assay(ELISA) was developed by using recombinant purified early antigens, EA-D and EA-R to detect IgA antibodies in sera from nasopharyngeal carcinoma(NPC) patients. 30 sera from NPC patients and 49 sera from normal persons were detected by the developed ELISA. The serum positive rate and antibody titer were compared with immunoenzymatic method(IE) on slide with Raji cells mears. ELISA is more sensitive and specific. The serum positive rate of NPC patients was increased from 70% by IE to 100% by ELISA and 77% of the serum antibody titer reached > or = 1:200. The results show that the expressed recombinant p138 and p54 antigens are effective for detection of EA/IgA antibody in sera from NPC patients and ELISA will be a sensitive, specific and convenient method for early diagnosis of NPC.
Epstein-Barr virus (EBV) virion capsid antigen (VCA) gp125 as a diagnostic antigen was expressed in infected cells by recombinant vaccinia virus. The presence of IgA antibody to VCA of EBV was tested by ELISA in sera from nasopharyngeal carcinoma (NPC) patients and normal individuals. The ELISA consisted of three steps involving test serum, mouse monoclonal antibody to human IgA and rabbit anti-mouse IgG. The antibody titers of sera determined by this way correlated well with those by IF. The GMT by ELISA was 12 times higher than that by IF. Furthermore, efforts to develop gold-conjugated immunosorbent assay (GCISA), which is a more sensitive assay for measuring IgA antibody to VCA, has met with initial results.